Spyre Therapeutics (SYRE) Selling, General & Administrative (2015 - 2026)
Spyre Therapeutics (SYRE) Selling, General & Administrative (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Spyre Therapeutics | 257.23 Mn | 257.23 Mn | - | 15.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.23 Mn |
| Dec 31, 2025 | 12.53 Mn |
| Sep 30, 2025 | 11.64 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 11.94 Mn |
| Dec 31, 2024 | 10.77 Mn |
| Sep 30, 2024 | 10.65 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Mar 31, 2024 | 12.85 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Sep 30, 2023 | 8.58 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Mar 31, 2023 | 5.23 Mn |
| Dec 31, 2022 | 5.08 Mn |
| Sep 30, 2022 | 6.95 Mn |
| Jun 30, 2022 | 7.68 Mn |
| Mar 31, 2022 | 8.83 Mn |
| Dec 31, 2021 | 7.30 Mn |
| Sep 30, 2021 | 6.84 Mn |
| Jun 30, 2021 | 6.82 Mn |